Objectives: to estimate the effect on the return to work of patients with neoplastic colorectal disease. Specifically, it was assessed whether and how the return to work affects the quality of life, and the psychological and social sphere of patients with colorectal carcinoma.
Design: in June 2018, a systematic review of the literature was performed, investigating the Medline (PubMed) and Scopus databases.
Setting and participants: the studies included in the review focused on patients with a diagnosis of colorectal cancer as a test population.
Main outcome measures: return to work in patients with a diagnosis of colorectal cancer.
Results: after the screening process, 10 articles were included in the research: • 6 studies assessed the effects that work and return to employment have on patients diagnosed with cancer; • 1 study assessed the effects of the disease and treatments on personal finances; • 1 study assessed the influence of medical treatments on the ability to return to work; • 1 study assessed the effect of the diagnosis of cancer on employment; • 1 study assessed the management of cancer diseases by employers. The included studies show a significant impact on the subjects' emotional sphere, with repercussions on employment levels that fall from 39% to 31% in the first 15 months after diagnosis. Complications and critical issues related to therapeutic pathways influence private finances. When compared to healthy subjects, cancer patients show a greater reduction in expenses for food or clothing (39% vs. 27%; p=0.001) and a higher probability of requiring loans (18% vs. 11%; p=0.007).
Conclusion: among the interventions that protect the well-being of the patient after the tumour disease, the returning to work is a crucial aspect. The impact that employment has on the quality of life of the patient and on the achievement of economic and social well-being for the individual and for the community are important.